Correlation Between Enzo Biochem and ProPhase Labs

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Enzo Biochem and ProPhase Labs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enzo Biochem and ProPhase Labs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enzo Biochem and ProPhase Labs, you can compare the effects of market volatilities on Enzo Biochem and ProPhase Labs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enzo Biochem with a short position of ProPhase Labs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enzo Biochem and ProPhase Labs.

Diversification Opportunities for Enzo Biochem and ProPhase Labs

0.25
  Correlation Coefficient

Modest diversification

The 3 months correlation between Enzo and ProPhase is 0.25. Overlapping area represents the amount of risk that can be diversified away by holding Enzo Biochem and ProPhase Labs in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ProPhase Labs and Enzo Biochem is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enzo Biochem are associated (or correlated) with ProPhase Labs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ProPhase Labs has no effect on the direction of Enzo Biochem i.e., Enzo Biochem and ProPhase Labs go up and down completely randomly.

Pair Corralation between Enzo Biochem and ProPhase Labs

Considering the 90-day investment horizon Enzo Biochem is expected to generate 0.19 times more return on investment than ProPhase Labs. However, Enzo Biochem is 5.14 times less risky than ProPhase Labs. It trades about 0.04 of its potential returns per unit of risk. ProPhase Labs is currently generating about -0.26 per unit of risk. If you would invest  102.00  in Enzo Biochem on August 29, 2024 and sell it today you would earn a total of  2.00  from holding Enzo Biochem or generate 1.96% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Enzo Biochem  vs.  ProPhase Labs

 Performance 
       Timeline  
Enzo Biochem 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Enzo Biochem has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Enzo Biochem is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.
ProPhase Labs 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ProPhase Labs has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Enzo Biochem and ProPhase Labs Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Enzo Biochem and ProPhase Labs

The main advantage of trading using opposite Enzo Biochem and ProPhase Labs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enzo Biochem position performs unexpectedly, ProPhase Labs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ProPhase Labs will offset losses from the drop in ProPhase Labs' long position.
The idea behind Enzo Biochem and ProPhase Labs pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Other Complementary Tools

Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes